Aro Biotherapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$101M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Aro Biotherapeutics's estimated annual revenue is currently $5.1M per year.(?)
  • Aro Biotherapeutics's estimated revenue per employee is $155,000
  • Aro Biotherapeutics's total funding is $101M.

Employee Data

  • Aro Biotherapeutics has 33 Employees.(?)
  • Aro Biotherapeutics grew their employee count by 32% last year.
  • Aro Biotherapeutics currently has 1 job openings.

Unlocking the Potential of Genetic Medicines\n\nBased in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.